The November 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/4zx9Zl5
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/4zx9Zl5
November 6, 2026 at 11:00 AM
The November 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/4zx9Zl5
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/4zx9Zl5
This year AJKD inducted six remarkable reviewers into the AJKD Reviewer Hall of Fame. The editors thank and congratulate these reviewers, all of whom shared why they participate in the peer review process:
bit.ly/4st9aag
#KidneyWk
bit.ly/4st9aag
#KidneyWk
2026 Inductees to the AJKD Reviewer Hall of Fame
In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial team. We continue the t…
bit.ly
October 27, 2026 at 6:53 PM
This year AJKD inducted six remarkable reviewers into the AJKD Reviewer Hall of Fame. The editors thank and congratulate these reviewers, all of whom shared why they participate in the peer review process:
bit.ly/4st9aag
#KidneyWk
bit.ly/4st9aag
#KidneyWk
Congratulations to the authors of these articles selected to receive the 2026 AJKD Editors' Choice Award:
bit.ly/4zcitxW
bit.ly/4zcitxW
2026 Editors’ Choice Award
In 2017, we established an annual celebration of articles that our editorial team designated as “Editors’ Choice” selections. The editors are delighted to recognize the articles listed below that h…
bit.ly
October 26, 2026 at 5:08 PM
Congratulations to the authors of these articles selected to receive the 2026 AJKD Editors' Choice Award:
bit.ly/4zcitxW
bit.ly/4zcitxW
This year AJKD inducted six remarkable reviewers into the AJKD Reviewer Hall of Fame. The editors thank and congratulate these reviewers, all of whom shared why they participate in the peer review process:
bit.ly/4st9aag
#KidneyWk
bit.ly/4st9aag
#KidneyWk
2026 Inductees to the AJKD Reviewer Hall of Fame
In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial team. We continue the t…
bit.ly
October 23, 2026 at 12:31 PM
This year AJKD inducted six remarkable reviewers into the AJKD Reviewer Hall of Fame. The editors thank and congratulate these reviewers, all of whom shared why they participate in the peer review process:
bit.ly/4st9aag
#KidneyWk
bit.ly/4st9aag
#KidneyWk
If you're at #KidneyWk, stop by @nkf-professionals.bsky.social booth #302 to pick up AJKD magnets!
October 23, 2026 at 12:57 PM
If you're at #KidneyWk, stop by @nkf-professionals.bsky.social booth #302 to pick up AJKD magnets!
Congrats to Dr Harold Feldman for 10 amazing years as AJKD Editor-in-Chief!
Kicking off his final Editorial Board meeting at #KidneyWk with many thanks to his editorial team and all the Ed Board members: ajkd.org/content/edbo...
Kicking off his final Editorial Board meeting at #KidneyWk with many thanks to his editorial team and all the Ed Board members: ajkd.org/content/edbo...
October 23, 2026 at 12:46 PM
Congrats to Dr Harold Feldman for 10 amazing years as AJKD Editor-in-Chief!
Kicking off his final Editorial Board meeting at #KidneyWk with many thanks to his editorial team and all the Ed Board members: ajkd.org/content/edbo...
Kicking off his final Editorial Board meeting at #KidneyWk with many thanks to his editorial team and all the Ed Board members: ajkd.org/content/edbo...
Congratulations to the authors of these articles selected to receive the 2026 AJKD Editors' Choice Award:
bit.ly/4zcitxW
#KidneyWk
bit.ly/4zcitxW
#KidneyWk
2026 Editors’ Choice Award
In 2017, we established an annual celebration of articles that our editorial team designated as “Editors’ Choice” selections. The editors are delighted to recognize the articles listed below that h…
bit.ly
October 23, 2026 at 12:29 PM
Congratulations to the authors of these articles selected to receive the 2026 AJKD Editors' Choice Award:
bit.ly/4zcitxW
#KidneyWk
bit.ly/4zcitxW
#KidneyWk
Many people starting dialysis could do it at home. So why do so few choose PD? An AJKD review asked patients, caregivers and clinicians. 🎧 nephspace.com/peritoneal-d...
October 17, 2026 at 3:24 PM
Many people starting dialysis could do it at home. So why do so few choose PD? An AJKD review asked patients, caregivers and clinicians. 🎧 nephspace.com/peritoneal-d...
🎉Congratulations to the incoming AJKD Editor-in-Chief, Dr Wolfgang Winkelmayer! 🎉
👏 Congratulations to Wolfgang Winkelmayer, MD, MPH, ScD, recipient of the 2027 David M. Hume Memorial Award!
Learn more ➡️ www.kidney.org/spring-clini...
📍 Join us at #NKFClinicals in Orlando this May as we celebrate our award winners. Early bird registration opens October 14.
Learn more ➡️ www.kidney.org/spring-clini...
📍 Join us at #NKFClinicals in Orlando this May as we celebrate our award winners. Early bird registration opens October 14.
October 16, 2026 at 1:56 PM
🎉Congratulations to the incoming AJKD Editor-in-Chief, Dr Wolfgang Winkelmayer! 🎉
AJKD Core Curriculum might just be my favorite thing in any journal
October 14, 2026 at 4:10 AM
AJKD Core Curriculum might just be my favorite thing in any journal
A pH of 7.22 in a patient on pressors: bicarbonate or not? In the blinded SODa-BIC trial (NEJM), the blood gas did improve. Did the patients?
And why do so few people start dialysis at home on PD? An AJKD review asked patients and nephrologists.
And why do so few people start dialysis at home on PD? An AJKD review asked patients and nephrologists.
October 12, 2026 at 4:21 PM
A pH of 7.22 in a patient on pressors: bicarbonate or not? In the blinded SODa-BIC trial (NEJM), the blood gas did improve. Did the patients?
And why do so few people start dialysis at home on PD? An AJKD review asked patients and nephrologists.
And why do so few people start dialysis at home on PD? An AJKD review asked patients and nephrologists.
The October 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
October 6, 2026 at 10:00 AM
The October 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
The October 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
October 4, 2026 at 4:00 PM
The October 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/46V3wDR
NEW Blog Commentary from AJKD Editorial Intern Dr. Elias John Elenjickal on the #AJKDBlog:
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
September 28, 2026 at 10:01 PM
NEW Blog Commentary from AJKD Editorial Intern Dr. Elias John Elenjickal on the #AJKDBlog:
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
NEW Blog Commentary from AJKD Editorial Intern Dr. Elias John Elenjickal on the #AJKDBlog:
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
September 24, 2026 at 5:00 PM
NEW Blog Commentary from AJKD Editorial Intern Dr. Elias John Elenjickal on the #AJKDBlog:
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
Rethinking Osteoporosis Therapy in Chronic Kidney Disease
bit.ly/4dPHXbp (FREE)
⚡️AJKD Express is an expedited consideration process for full-length original research articles: Authors of eligible #AJKDExpress articles will be notified of decision within 7-16 business days.⚡️
Details on #AJKDBlog: bit.ly/2Ws8rtp
Details on #AJKDBlog: bit.ly/2Ws8rtp
September 20, 2026 at 10:00 AM
⚡️AJKD Express is an expedited consideration process for full-length original research articles: Authors of eligible #AJKDExpress articles will be notified of decision within 7-16 business days.⚡️
Details on #AJKDBlog: bit.ly/2Ws8rtp
Details on #AJKDBlog: bit.ly/2Ws8rtp
The September 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
Highlights from the August 2026 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was…
bit.ly
September 4, 2026 at 10:00 PM
The September 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
The September 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
Highlights from the August 2026 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was…
bit.ly
September 1, 2026 at 5:06 PM
The September 2026 issue of AJKD is available now!
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters:
bit.ly/3TbdJZr
11/ Early recognition is key, because time to complement inhibition meaningfully affects renal recovery. Fakhouri et al (AJKD 2016) found reduced efficacy beyond 2 weeks from diagnosis. In mHTN-TMA, expect a response within 7 to 15 days of BP control. @ajkd.bsky.social
August 21, 2026 at 2:17 PM
11/ Early recognition is key, because time to complement inhibition meaningfully affects renal recovery. Fakhouri et al (AJKD 2016) found reduced efficacy beyond 2 weeks from diagnosis. In mHTN-TMA, expect a response within 7 to 15 days of BP control. @ajkd.bsky.social
むるぬの中でmost-anticipated moemoe metroidvaniaを受賞しているのこれ
www.youtube.com/watch?v=aJKD...
www.youtube.com/watch?v=aJKD...
INARI - Official Announcement Trailer
YouTube video by Indie Games Hub
www.youtube.com
August 21, 2026 at 12:26 PM
むるぬの中でmost-anticipated moemoe metroidvaniaを受賞しているのこれ
www.youtube.com/watch?v=aJKD...
www.youtube.com/watch?v=aJKD...
Special Collection: These articles highlight recent research published in AJKD on developments in kidney transplantation and its impact on donors and recipients.
bit.ly/2wAeRIo (FREE until August 20, 2026)
bit.ly/2wAeRIo (FREE until August 20, 2026)
August 17, 2026 at 1:21 PM
Special Collection: These articles highlight recent research published in AJKD on developments in kidney transplantation and its impact on donors and recipients.
bit.ly/2wAeRIo (FREE until August 20, 2026)
bit.ly/2wAeRIo (FREE until August 20, 2026)
Interview in AJKD blog @ajkd.bsky.social on closure of dialysis facilities ajkdblog.org/2026/08/12/d...
Their speculation is very superficial on causes. Reading the USRDS report makes it clear why units are closing!
@christosargyrop.bsky.social @ericweinhandl.bsky.social
Their speculation is very superficial on causes. Reading the USRDS report makes it clear why units are closing!
@christosargyrop.bsky.social @ericweinhandl.bsky.social
Dialysis Facility Closure Trends Over the Past Decade: An Interview
Between 2006 and 2016, the number of US dialysis facilities experienced steady annual growth. Recent data suggest a reversal in this trend. Varkila et al examined trends in US dialysis facility clo…
ajkdblog.org
August 12, 2026 at 2:01 PM
Interview in AJKD blog @ajkd.bsky.social on closure of dialysis facilities ajkdblog.org/2026/08/12/d...
Their speculation is very superficial on causes. Reading the USRDS report makes it clear why units are closing!
@christosargyrop.bsky.social @ericweinhandl.bsky.social
Their speculation is very superficial on causes. Reading the USRDS report makes it clear why units are closing!
@christosargyrop.bsky.social @ericweinhandl.bsky.social
Massive (f/ Horace Andy)
www.youtube.com/watch?v=aJkd...
www.youtube.com/watch?v=aJkd...
Massive Attack - Everywhen (Extended Remix with Horace Andy)
YouTube video by DaPhunkPhenomena
www.youtube.com
January 22, 2025 at 2:14 AM
Massive (f/ Horace Andy)
www.youtube.com/watch?v=aJkd...
www.youtube.com/watch?v=aJkd...
Rituximab 💉and HBV🦠 Prophylaxis
Active HBV --> Avoid ritux ❎
HBV carrier state --> prophylaxis for 18 months ✅
Prior HBV infection --> Moniter every 3 months 🧐
.
source - AJKD core curriculum
www.ajkd.org/article/S027...
#Nephsky
#Medsky
Active HBV --> Avoid ritux ❎
HBV carrier state --> prophylaxis for 18 months ✅
Prior HBV infection --> Moniter every 3 months 🧐
.
source - AJKD core curriculum
www.ajkd.org/article/S027...
#Nephsky
#Medsky
April 15, 2025 at 3:46 PM
Rituximab 💉and HBV🦠 Prophylaxis
Active HBV --> Avoid ritux ❎
HBV carrier state --> prophylaxis for 18 months ✅
Prior HBV infection --> Moniter every 3 months 🧐
.
source - AJKD core curriculum
www.ajkd.org/article/S027...
#Nephsky
#Medsky
Active HBV --> Avoid ritux ❎
HBV carrier state --> prophylaxis for 18 months ✅
Prior HBV infection --> Moniter every 3 months 🧐
.
source - AJKD core curriculum
www.ajkd.org/article/S027...
#Nephsky
#Medsky